We are live on ! Find out more
AWM

Avitas Wealth Management Portfolio holdings

AUM $723M
1-Year Est. Return 33.35%
This Fund
S&P 500
This Quarter Est. Return
+4.47%
1 Year Est. Return
+33.35%
3 Year Est. Return
+56.18%
5 Year Est. Return
+244.92%
10 Year Est. Return
AUM
$723M
AUM Growth
+$11.5M
Cap. Flow
-$4.36M
Cap. Flow %
-0.6%
Top 10 Hldgs %
36.1%
Holding
204
New
7
Increased
72
Reduced
111
Closed
14

Top Sells

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$2.7M
2
PFE icon
Pfizer
PFE
+$2.48M
3
ELV icon
Elevance Health
ELV
+$2.43M
4
MCHP icon
Microchip Technology
MCHP
+$1.93M
5
RIO icon
Rio Tinto
RIO
+$1.88M

Sector Composition

Rank Sector Weight
1 Technology 30.94%
2 Financials 12.92%
3 Consumer Discretionary 9.23%
4 Healthcare 8.27%
5 Communication Services 7.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RIO icon
201
Rio Tinto
RIO
$149B
-26,456
Closed -$1.88M
TECK icon
202
Teck Resources
TECK
$28.8B
-33,672
Closed -$1.76M
XHB icon
203
State Street SPDR S&P Homebuilders ETF
XHB
$1.69B
-1,823
Closed -$227K
XME icon
204
State Street SPDR S&P Metals & Mining ETF
XME
$3.9B
-3,468
Closed -$221K

Similar funds

Avitas Wealth Management's Q4 2024 Portfolio in Review

As of Q4 2024, Avitas Wealth Management held 204 positions worth $723M, up 1.6% from $711M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Avitas Wealth Management's Q4 2024 filing shows 7 new, 72 increased, 111 reduced and 14 closed positions. Its largest new stake was Cardinal Health: 12,395 shares worth $1.47M. The largest sale was Amgen, an estimated $2.7M.

By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 31% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Avitas Wealth Management's largest Q4 2024 buy was Cardinal Health: 12,395 shares worth $1.47M.
  • Avitas Wealth Management added most to State Street Health Care Select Sector SPDR ETF in Q4 2024, an estimated $7.58M increase.
  • Avitas Wealth Management's biggest Q4 2024 reduction was AstraZeneca, cutting an estimated $1.33M.
  • Avitas Wealth Management fully exited Amgen in Q4 2024, selling an estimated $2.7M.
  • Avitas Wealth Management's ten largest holdings make up 36% of its $723M portfolio in Q4 2024.
  • Avitas Wealth Management opened 7 new positions and closed 14 in Q4 2024.
  • Avitas Wealth Management's portfolio value rose 1.6% quarter-over-quarter to $723M.

Based on Avitas Wealth Management's 13F filing for Q4 2024, filed 27 Jan 2025.